Key result
Ginsenoside Rg1 improves LVEF and suppresses ER stress in doxorubicin-induced cardiotoxicity.
Why the study?
Ginsenoside Rg1 protects hearts from diverse cardiovascular diseases, but its protective role against doxorubicin-induced cardiotoxicity and effects on endoplasmic reticulum stress and autophagy needed investigation.
Does ginsenoside Rg1 prevent doxorubicin-induced cardiotoxicity by inhibiting autophagy and endoplasmic reticulum stress in mice?
Does ginsenoside Rg1 prevent doxorubicin-induced cardiotoxicity by inhibiting autophagy and endoplasmic reticulum stress in mice?
Preclinical evidence in mice suggests ginsenoside Rg1 mitigates doxorubicin-induced cardiotoxicity and preserves left ventricular function by suppressing excessive endoplasmic reticulum stress and autophagy.
Answers are grounded in this paper and cite their sources.
Should not yet change clinical practice; hypothesis-generating for ginsenoside Rg1 in doxorubicin cardiotoxicity.
Ginsenoside Rg1, a saponin that is a primary component of ginseng, has been demonstrated to protect hearts from diverse cardiovascular diseases with regulating multiple cellular signal pathways. In the present study, we investigated the protective role of ginsenoside Rg1 on doxorubicin-induced cardiotoxicity and its effects on endoplasmic reticulum stress and autophagy. After pre-treatment with ginsenoside Rg1 (50 mg/kg i.g.) for 7 days, male C57BL/6J mice were intraperitoneally injected with a single dose of doxorubicin (6 mg/kg) every 3 days for four injections. Echocardiographic and pathological findings showed that ginsenoside Rg1 could significantly reduce the cardiotoxicity induced by doxorubicin. Ginsenoside Rg1 significantly inhibited doxorubicin-induced formation of autophagosome. At the same time, ginsenoside Rg1 decreased the doxorubicin-induced cardiac microtubule-associated protein-light chain 3 and autophagy related 5 expression. Ginsenoside Rg1 can reduce endoplasmic reticulum dilation caused by doxorubicin. Compared with the doxorubicin group, the expression of cleaved activating transcription factor 6 and inositol-requiring enzyme 1 decreased in group ginsenoside Rg1. Treatment with ginsenoside Rg1 reduces the expression of TIF1 and increases the expression of glucose-regulated protein 78. In the ginsenoside Rg1 group, the expression of p-P70S6K, c-Jun N-terminal kinases 1 and Beclin1 declined. These results indicate that ginsenoside Rg1 may improve doxorubicin-induced cardiac dysfunction by inhibiting endoplasmic reticulum stress and autophagy.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2018) studied Doxorubicin-induced cardiotoxicity (n=30). Ginsenoside Rg1 vs. Doxorubicin alone (6 mg/kg i.p. every 3 days for 4 injections) and PBS normal control was evaluated on Left ventricular ejection fraction (LVEF) and fractional shortening (LVFS), myocardial pathology, and markers of autophagy and endoplasmic reticulum stress (p=<0.05). Ginsenoside Rg1 improved left ventricular ejection fraction and fractional shortening while inhibiting autophagy and ER stress in doxorubicin-treated mice.
Synapse has enriched 10 related papers. Consider them for comparative context: